POUL SØRENSEN
Partner at Ventac Partners
FormerInvestor
Updated: ·
About
Poul Sørensen is Partner at Ventac Partners.
Experience
Partner
Ventac PartnersJan 2018 - Dec 2022
Partner and Entrepreneur-in-ResidenceCurrent
ARGOBIOJan 2022 - Present
Global Head of Corporate Strategy & Business Development
Medday PharmaceuticalsJan 2019 - Dec 2020
Co-founder & Chief Scientific OfficerCurrent
Allero TherapeuticsJan 2016 - Present
Honorary Professor of BiomedicineCurrent
Aarhus UniversityJan 2015 - Present
Senior Vice President, Global Head of Strategic Development
Stallergenes GreerJan 2012 - Dec 2017
Vice President, Global Research
ALK AbellóJan 2008 - Dec 2012
Research Director
LEO PharmaJan 2005 - Dec 2008
Member Board Of Directors
Biotech Research & Innovation Centre (BRIC), University of CopenhagenJan 2005 - Dec 2011
Vice President, Head of Antibody Therapeutics Business Unit
Micromet AGJan 2003 - Dec 2004
Director, Biopharmaceutical Project Portfolio
Maxygen, IncJan 2001 - Dec 2003
Head of Biology
Active Biotech Research ABJan 1998 - Dec 2001
Scientific Project Leader
Pharmacia & UpjohnJan 1994 - Dec 1998
Research associate/PhD student
Carlsberg LaboratoryJan 1989 - Dec 1994
Frequently Asked Questions
Who is Poul Sørensen?
Poul Sørensen is Partner at Ventac Partners, based in Paris, France.